e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Inflammation and remodelling in human lungs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytosolic phospholipase A
2
type IVβ induces interleukin – 8 and cyclooxygenase -2 gene expression but does not influence IL-16 and heme oxygenase-1 transcription in human lung cells
R. Pawliczak, C. Logun, G. Woszczek, A. Ptasinska, M. L. Kowalski, T. Wu, J. H. Shelhamer (Lodz, Poland; Bethesda, Pittsburgh, United States Of America)
Source:
Annual Congress 2004 - Inflammation and remodelling in human lungs
Session:
Inflammation and remodelling in human lungs
Session type:
Oral Presentation
Number:
4179
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Pawliczak, C. Logun, G. Woszczek, A. Ptasinska, M. L. Kowalski, T. Wu, J. H. Shelhamer (Lodz, Poland; Bethesda, Pittsburgh, United States Of America). Cytosolic phospholipase A
2
type IVβ induces interleukin – 8 and cyclooxygenase -2 gene expression but does not influence IL-16 and heme oxygenase-1 transcription in human lung cells. Eur Respir J 2004; 24: Suppl. 48, 4179
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
IL-8 and COX-2 expression is regulated through cPLA2-derived arachidonate metabolites in human lung cells
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
Role of arginase and NOS2 in the regulation of CCL18 release
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 29s
Year: 2004
PDK1/RSK1-dependent C/EBPß activation is involved in thrombin-induced expression of orosomucoid 1-like 3 (ORMDL3) and IL-8/CXCL8 in human lung epithelial cells
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Inhibition of histone acetyltransferases attenuates cytokine and LPS-induced up-regulation of arginase in rat alveolar macrophages
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006
p38 MAPK/MSK1/CREB signal pathway involves in transforming growth factor-β-induced heme oxygenase-1 expression in human lung epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 544s
Year: 2007
Peroxiredoxin 6 attenuates lipopolysaccharide-induced plasminogen activatro inhibitor 1 expression by regulating autophagy
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Calprotectin stimulates interleukin 8 release from A549 cells
Source: Eur Respir J 2002; 20: Suppl. 38, 372s
Year: 2002
Dexamethasone inhibits LPS-induced expression of human β-defensin-2 via down-regulation of TLR4
Source: Eur Respir J 2003; 22: Suppl. 45, 562s
Year: 2003
IL-13 enhances GSNO reductase activity and decreases intracellular S-nitrosothiols in lung epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 103s
Year: 2006
Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
Thrombin induces stomatin-like protein 2 (STOML2) expression and IL-8/CXCL8 release by ROCK, JNK, and PEA3 pathways in human lung epithelial cells
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
IL-13 induces glucocorticoid resistance in iNOS expression and activity in human airway epithelial cells (HAECs)
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Proteinase-activated receptor-2 (PAR
2
) activation on human lung fibroblasts increases IL-6 & IL-8 mRNA expression
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages
Source: Eur Respir J 2007; 29: 986-994
Year: 2007
Apocynin augments IL-6, IL-8 and TNF expression in A549 cells
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1 in human lung fibroblasts
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Phosphodiesterase 4 and 5 inhibitors decrease HO-1 and IL-8 gene expression induced by cigarette smoke
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept